British Columbia Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-17,917
Closed -$1.77M 691
2017
Q3
$1.77M Buy
17,917
+8,000
+81% +$776K 0.01% 641
2017
Q2
$1M Hold
9,917
0.01% 671
2017
Q1
$1.15M Sell
9,917
-9,130
-48% -$1.06M 0.01% 655
2016
Q4
$2.29M Sell
19,047
-19,226
-50% -$2.13M 0.02% 612
2016
Q3
$4.3M Sell
38,273
-10,462
-21% -$1.21M 0.04% 476
2016
Q2
$6.04M Sell
48,735
-18,128
-27% -$2.19M 0.05% 398
2016
Q1
$7.52M Buy
66,863
+40,475
+153% +$4.2M 0.07% 319
2015
Q4
$2.87M Buy
26,388
+17,816
+208% +$2.04M 0.03% 567
2015
Q3
$855K Sell
8,572
-242
-3% -$26.3K 0.01% 646
2015
Q2
$1M Buy
8,814
+242
+3% +$29.3K 0.01% 672
2015
Q1
$896K Buy
8,572
+3,581
+72% +$382K 0.01% 652
2014
Q4
$601K Sell
4,991
-24
-0.5% -$3.15K 0.01% 668
2014
Q3
$734K Sell
5,015
-538
-10% -$83K 0.01% 636
2014
Q2
$928K Sell
5,553
-4,906
-47% -$873K 0.01% 623
2014
Q1
$2.08M Sell
10,459
-1,306
-11% -$247K 0.02% 543
2013
Q4
$2.25M Buy
11,765
+1,256
+12% +$234K 0.02% 532
2013
Q3
$1.78M Sell
10,509
-3,687
-26% -$572K 0.02% 566
2013
Q2
$2.15M Buy
+14,196
New +$2.01M 0.02% 541

Other funds holding CLB

British Columbia Investment Management's CLB Position: Q4 2017 in Review

British Columbia Investment Management sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 17,917 shares — an estimated $1.77M sold.

British Columbia Investment Management first reported a position in CLB in Q2 2013 and held it in 18 quarters. The position peaked at $7.52M in Q1 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • British Columbia Investment Management reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • British Columbia Investment Management sold 17,917 Core Laboratories shares in Q4 2017, an estimated $1.77M.
  • British Columbia Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 18 quarters.
  • British Columbia Investment Management's Core Laboratories position peaked at $7.52M in Q1 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on British Columbia Investment Management's 13F filing for Q4 2017, filed 20 Feb 2018.